Illustrative image – not actual.Dabur India, in its bid to expand its consumer care business, is likely to acquire Fem Care Pharma for about Rs.300 crore and both the companies are likely to sign agreement to this effect by end-November 2008.
It is learnt that KPMG is the advisor for the deal. The other companies that were in the race to bid for Fame Care were Godrej Group and Marico.
Also See:
Dabur India's UAE plant to commence production by December(10-Oct-08)
